Vimarsana
Biggest News Aggregation in the World

Floor Effect News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Floor Effect. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Floor Effect Today - Breaking & Trending Today

BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn - Vimarsana News

BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn

The data will be presented at the Annual ALS Drug Development Summit, which is focused on identifying transformative ALS targets, seeking translational biomarkers and propelling more clinical...

BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS - Vimarsana News

BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments - Vimarsana News

BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments

NEW YORK, Dec. 26, 2023 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today provided an update on the grant...

BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS - Vimarsana News

BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS

Meeting Provided a Clear Path for Planned Phase 3b Trial NEW YORK, Dec. 7, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for...

BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS - Vimarsana News

BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS

Meeting will take place on December 6; Company plans to seek Special Protocol Assessment NEW YORK, Nov. 20, 2023 /PRNewswire/ --BrainStorm Cell Therapeutics Inc. , a leading developer of adult...